Notice on blood pressure control in patients with type 2 diabetes mellitus

Czech version

Authors: Andrej Dukát; Juraj Payer; Peter Jackuliak; Martin Jankovský; Samuel Nachtmann; Juraj Smaha
Authors‘ workplace: V. interná klinika LF UK a UNB, Nemocnica Ružinov, Bratislava
Published in: Forum Diab 2025; 14(2): 142-143
Category: News

Overview

Hypertension control among patients with type 2 diabetes represents one of the basic problems in the current clinical pharmacotherapy. Despite published the one whole issue number, conclusions are still changing. Recently results of the large intervention trial BPROAD from China were published. As the topic of blood pressure among diabetic patients is important for our clinical practice, this short review deals with the optimal blood pressure control in patients with type 2 diabetes, that is useful for the clinical practice.

Keywords:

hypertension – diabetes mellitus – therapy – blood pressure

Sources

[American Diabetes Association Proffessional Practice Committee]. 10. Cardiovascular disease and risk management: standards of care in diabetes-2024.Diabetes Care 2024 : 47(Suppl 1): S179-S218. Dostupné z DOI: <http://dx.doi.org/10.2337/dc24-S010>.

Mancia G, Kreutz R, Brunstrom M et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens 2023 : 41(12): 1874–2071. Dostupné z DOI: <http://dx.doi.org/10.1097/HJH.0000000000003480>. Erratum in J Hypertens 2024; 42(1): 194. Dostupné z DOI: <http://dx.doi.org/10.1097/HJH.0000000000003621>.

McEvoy JW, McCarthy CP, Bruno RM et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J 2024 : 45(38): 3912–4018. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehae178>.

Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet 2012 : 380(9841): 601–610. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140–6736(12)60987–8>.

Dukát A. Diabetes hypertenzia a dyslipidémia –⁠ letálne trio. Forum Diab 2015 : 4(1): 62–66.

Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol 2023 : 20(10): 685–695. Dostupné z DOI: <http://dx.doi.org/10.1038/s41569–023–00877-z>.

Tsujimoto T, Kajio H. Benefits of intensive blood pressure treatment in patients with type 2 diabetes nellitus receiving standard but not intensive glycemic control. Hypertension 2018 : 72(2): 323–330. Dostupné z DOI: <http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.11408>.

Bi Y, Li M, Liu Y et al. Intensive Blood-Pressure Control in Patients with Type 2 Diabetes. N Engl J Med 2025; 392(12): 1155–1167. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa2412006>.

Fernandez-Fernandez B, Sarafidis P, Ortiz A. Intensive Blood-Pressure Control in Patients with Type 2 Diabetes. N Engl J Med 2025 : 393(1): 96–97. Dostupné z DOI: <http://doi:10.1056/NEJMv2506053>.

Cushman WC , Evans GW, Byington RP et al. [ACCORD Study Group]. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010 : 362(17): 1575–1585. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1001286>.

[The SPRINT Research Group]. Final report of a trial of intensive versus standard blood-pressure control. N Engl J Med 2021 : 384(20): 1921–1930. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1901281>.

Liu J, Li Y, Ge J et al. Lowering systolic blood pressure to less than 120 mmHg versus less than 140 mmHg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial. Lancet 2024 : 404(10449): 245–255. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140–6736(24)01028–6>.